Our revolutionary method for molecular diagnostics, enabling limitless testing possibilities.
Results that providers and patients can trust
Integrates into provider workflows
Low COGS enables broad patient access
Works under a wide range of assay conditions
Adaptable to a variety of molecular targets, multiplexing formats, and legacy systems
DETECTR® searches for the presence of specific nucleic acids in a sample that are indicative of disease, providing actionable clinical information.
Our proprietary testing system works by employing CRISPR nucleases, programmed to find a defined gene sequence. Upon finding the sequence of interest, the nuclease activates a cleavage capability, which generates a signal. The signal confirms the sequence has been found.
At Mammoth we’re bringing CRISPR out of the lab and into everyday life.
to lower complexity instruments, instrument-free testing
with new targets, panels, applications, disease areas
by boosting performance metrics to enable lifecycle management
Affordable and timely molecular detection is needed in hospitals, point of care settings, and homes. Our DETECTR® platform can be integrated into different products by ourselves or our partners with an expansive test menu.
Mammoth is committed to advancing science internally and through collaborations in the service of its mission to discover, develop and commercialize drugs to improve the lives of patients. Please get in touch with us below if you would like to join us on our journey.